Olivier Allangba

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial

Aurore Perrot, Cyrille Touzeau, Jérôme Lambert et al. · Blood · 2025 · 21 citations · Full text

Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression

Laurane Cottin, Jérémie Riou, Corentin Orvain et al. · British Journal of Haematology · 2019 · 15 citations · Full text

Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in a population of newborns from Ivory Coast

Foungotin H Coulibaly, Gustave Koffi, Honoré A Touré et al. · Clinical Biochemistry · 2000 · 10 citations